Dr Reddy's launches generic antihistamine tablets in US
Jan 25 2013 , New Delhi
The company has launched generic desloratadine orally disintegrating tablets in the strengths of 2.5 mg and 5 mg in the US market on January 24, 2013, Dr Reddy's Laboratories (DRL) said in a statement.
This follows approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), it added.
The tablets are bio equivalent generic version of Schering Corp's Clarinex Reditabs tablets, DRL said.
"Clarinex Reditabs brand had US sales of approximately $5.3 million for the most recent twelve months ending November 2012 according to IMS Health," it added.
Shares of Dr Reddy's Laboratories today closed at Rs 1,942.55 on BSE, up 0.68% from its previous close.